机构

• 上海药物研究所 [61]

采集方式

• OAI收割 [61]

内容类型

• 期刊论文 [61]

发表日期

• 2024 [1]
• 2023 [4]
• 2022 [3]
• 2021 [4]
• 2020 [3]
• 2019 [4]
• 更多

学科主题

• Pharmacolo... [2]
• Cell Biolo... [1]
• Chemistry [1]

筛选

浏览/检索结果: 共61条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Species discrimination of multiple botanical origins of Fritillaria species based on infrared spectroscopy, thin layer chromatography-image analysis and untargeted metabolomics 期刊论文  OAI收割 PHYTOMEDICINE, 2024, 卷号: 123, 页码: 11 作者:  An, Ya-Ling;  Li, Yun;  Wei, Wen-Long;  Li, Zhen-Wei;  Zhang, Jian-Qing   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/01/26 Species discrimination  Fritillaria species  Infrared spectroscopy  Thin layer chromatography-image analysis  Untargeted metabolomics   Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2 期刊论文  OAI收割 CELL REPORTS, 2023, 卷号: 42, 期号: 11, 页码: 19 作者:  Zhu, Shengnan;  Yuan, Qingning;  Li, Xinzhu;  He, Xinheng;  Shen, Shiyi   |  收藏  |  浏览/下载：99/0  |  提交时间：2024/01/16 different ligands  recognition  ligand selectivity  receptor   Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis 期刊论文  OAI收割 PHARMACOLOGICAL RESEARCH, 2023, 卷号: 197, 页码: 12 作者:  Tang, Shuai;  Duan, Yichen;  Yuan, Tao;  Hu, Yutinh;  Yuan, Liang   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/11 KRAS  Pancreatic ductal adenocarcinoma  MAPK pathway  Tetrandrine  TRAIL  Death receptors   A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 10 作者:  Zhang, Yumin;  Sun, Yuan;  Xie, Yuanchao;  Shang, Weijuan;  Wang, Zhen   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/12/08 Conserved class B GPCR activation by a biased intracellular agonist 期刊论文  OAI收割 NATURE, 2023, 页码: 25 作者:  Zhao, Li-Hua;  He, Qian;  Yuan, Qingning;  Gu, Yimin;  He, Xinheng   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 Absorption, distribution, metabolism, and excretion of [C-14]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats 期刊论文  OAI收割 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 页码: 12 作者:  Li, Xin-mei;  Zheng, Yuan-dong;  Zhang, Yi-fan;  Huan, Xia-juan;  Yang, Chen   |  收藏  |  浏览/下载：30/0  |  提交时间：2022/12/13 [C-14]Mefuparib  Mefuparib (CVL218)  Blood-brain barrier  Mass balance  Tissue distribution  GastroPlus simulation   SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors 期刊论文  OAI收割 CELL RESEARCH, 2022, 页码: 21 作者:  Wang, Xiaomin;  Chen, Ziqi;  Xu, Jun;  Tang, Shuai;  An, Nan   |  收藏  |  浏览/下载：39/0  |  提交时间：2022/06/15 Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 9 作者:  Qian, Hong-jie;  Wang, Yu;  Zhang, Meng-qi;  Xie, Yuan-chao;  Wu, Qing-qing   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/06/15 VV116  nucleoside analog  SARS-CoV-2  safety  pharmacokinetics  healthy subjects   Exploring biological basis of Syndrome differentiation in coronary heart disease patients with two distinct Syndromes by integrated multi-omics and network pharmacology strategy 期刊论文  OAI收割 Chinese Medicine, 2021, 卷号: 16, 期号: 1 作者:  Wu,Gaosong;  Zhao,Jing;  Zhao,Jing;  Song,Nixue;  Zheng,Ningning   |  收藏  |  浏览/下载：49/0  |  提交时间：2021/12/01 Coronary heart disease  Syndrome differentiation  Traditional Chinese Medicine  Proteomics  Metabolomics  Network pharmacology   PARP14 inhibits microglial activation via LPAR5 to promote post-stroke functional recovery 期刊论文  OAI收割 AUTOPHAGY, 2021, 卷号: 17, 期号: 10, 页码: 2905-2922 作者:  Tang, Ying;  Liu, Jinchang;  Wang, Yu;  Yang, Li;  Han, Bing   |  收藏  |  浏览/下载：42/0  |  提交时间：2022/01/04 Autophagy  functional recovery  ischemic stroke  lysophosphatidic acid receptor 5  microglial activation  poly (ADP-ribose) polymerase 14